Immunotherapy and monoclonal antibody treatment are often accompanied by allergic response elicitation and adverse events during treatment, for example, in oral food allergen desensitization20, 21 and in individuals treated with an anti‐IgE antibody (omalizumab) in asthma.22 This evidence concerns the gene IGHE and asthma.